Sagent Pharm Inc (SGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,505 | -4,988 | -21,882 | -3,945 | -2,150 |
| Depreciation Amortization | 4,415 | 1,703 | 13,681 | 8,796 | 6,127 |
| Income taxes - deferred | -2,117 | -1,466 | -28,025 | 457 | 800 |
| Accounts receivable | -3,186 | -1,156 | -9,250 | -760 | -1,634 |
| Other Working Capital | -19,008 | -18,575 | -18,839 | -19,763 | -7,131 |
| Other Operating Activity | 10,604 | 7,855 | 56,792 | 2,327 | 2,293 |
| Operating Cash Flow | $-14,797 | $-16,627 | $-7,523 | $-12,888 | $-1,695 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,052 | -2,339 | -6,711 | -5,057 | -3,193 |
| Net Acquisitions | -1,694 | -1,694 | -11,785 | -11,785 | N/A |
| Purchase Of Investment | -7,216 | -2,003 | -13,212 | -10,202 | -5,221 |
| Sale Of Investment | 7,100 | 2,000 | 11,420 | 8,320 | 3,450 |
| Purchase Sale Intangibles | 3,800 | 2,000 | -1,707 | -1,109 | -768 |
| Other Investing Activity | 3,800 | 2,000 | -1,707 | -1,109 | -768 |
| Investing Cash Flow | $-4,062 | $-2,036 | $-21,995 | $-19,833 | $-5,732 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,966 | 3,135 | N/A | N/A | 0 |
| Debt Repayment | -3,158 | -1,584 | -471 | -411 | -340 |
| Common Stock Issued | 93 | 0 | 9,345 | 9,417 | 8,416 |
| Other Financing Activity | -202 | -79 | -5,371 | -5,388 | -5,295 |
| Financing Cash Flow | $4,699 | $1,472 | $3,503 | $3,618 | $2,781 |
| Exchange Rate Effect | 722 | 733 | -656 | -680 | -42 |
| Beginning Cash Position | 28,962 | 28,962 | 55,633 | 55,633 | 55,633 |
| End Cash Position | 15,524 | 12,504 | 28,962 | 25,850 | 50,945 |
| Net Cash Flow | $-13,438 | $-16,458 | $-26,671 | $-29,783 | $-4,688 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,797 | -16,627 | -7,523 | -12,888 | -1,695 |
| Capital Expenditure | -6,052 | -2,339 | -6,711 | -5,057 | -3,193 |
| Free Cash Flow | -20,849 | -18,966 | -14,234 | -17,945 | -4,888 |